Ad
related to: jnj yahoo stock
Search results
Results from the WOW.Com Content Network
Johnson & Johnson (NYSE: JNJ) is an elite dividend stock. The healthcare giant has increased its dividend payment for 62 years in a row. The iconic healthcare company backs its high-yielding ...
Johnson & Johnson is an ideal stock for investors more concerned with stable, passive income than total returns. The stock offers a 3% starting yield, and its annual increase has averaged around 6 ...
Keep in mind that Johnson & Johnson is among the exclusive stock market group of Dividend Kings with its 62-year record of annual dividend increases. The current quarterly rate of $1.24 per share ...
Healthcare stock Johnson & Johnson has been battered over fears of new scrutiny during the incoming Trump administration. The second Dividend King to buy is Johnson & Johnson (NYSE:JNJ). It's ...
Johnson & Johnson's stock trades at a forward P/E ratio of just over 13, a compelling value for such a quality business -- even if analysts only expect 5% to 6% annualized long-term earnings ...
Image source: The Motley Fool. Johnson & Johnson (NYSE: JNJ) Q4 2024 Earnings Call Jan 22, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Dow stock No. 2 to buy hand over fist in 2025: Johnson & Johnson. A second Dow Jones stock that can be confidently bought in the new year is healthcare conglomerate Johnson & Johnson (NYSE: JNJ ...
Johnson & Johnson (JNJ) closed the most recent trading day at $170.81, moving -1.01% from the previous trading session.
Ad
related to: jnj yahoo stock